Login

CEO Spotlight: MeridianLink CEO Nicolaas Vlok shares what excites him most about joining the #NYSECommunity now that his company is public. 00:10:00

Share On Facebook Share On Twitter

Nicolaas Vlok | CEO - MeridianLink, Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
"Understanding Canadian Consumer Debt and Subscriptions with Elizabeth Naumovski"
00:00:00
GeNeuro homes in on ancestral viral genes to treat autoimmune diseases - Jesús Martin-Garcia, Chief Executive Officer, Geneuro
00:10:00
focus has given them experience and expertise|Jared Franklin,Vice President,Costanoa Ventures
00:10:00
Exploring Canada's Uranium Frontier: Fission Uranium Corp.
00:10:00
Phil Bolan Discusses Financial Wellness Month and Budgeting Tips
00:10:00
William Huang, chairman, founder, and CEO of GDS Holdings, discusses his Chinese data center company's IPO and growth strategy.
00:10:00
Guy Hands Discusses Future of Alternative Investments and Global Challenges | Guy Hands, Chairman, Terra Firma Capital Partners.
00:00:00
Harry Fleming, CEO, Nobilis Health Corp
00:10:00
Insights into Venture Capital with Bill Comfort
00:10:00
Energy Transition Minerals: Strategic Update and Greenland Project Overview
00:10:00
Update on Lundin Gold: On Track for First Gold in a Year
00:10:00
Karim Awad on EFG Hermes' Acquisition of 51% Stake in AIB and Transformation to Universal Bank | Karim Awad , CEO, Egypt EFG Hermes.

© 2017 - Neuhu+